Category: Baxter International
Federal regulators close an investigation into Baxter's Chinese operations without taking any action against the healthcare giant.
MASSDEVICE ON CALL — Baxter (NYSE:BAX) closed the books on a federal bribery investigation after regulators dropped the probe without finding wrongdoing, the company announced.
The FDA warns Baxter International about problems with its HomeChoice dialysis device and with drug infusion pumps made at a pair of plants.
The FDA sent warning letters to Baxter (NYSE:BAX) this year, flagging infractions at an Illinois plant where Baxter makes its HomeChoice dialysis device and at a California plant that makes drug infusion pumps.
Baxter International accuses Johnson & Johnson's Ethicon SurgiFlo line of infringing several patents covering Baxter's FloSeal surgical hemostasis line.
Baxter International beats Wall Street's sales and earnings expectations, but costs from its $4 billion acquisition of Gambro push profits down.
Nikkiso America completed its deal for Baxter's continuous renal replacement therapy for treating acute kidney injury.
Nikkiso America said it closed the buyout of Baxter's (NYSE:BAX) continuous renal replacement therapy business for an undisclosed sum.
NxStage Medical and Gambro Renal settle a lawsuit and renew their dialysis tubing supply deal.
Medtronic plans to boost its footprint in Puerto Rico with a $6 million expansion that will bring 150 new jobs to the Isla del Encanto.